- Full text PDF available (1)
- This year (0)
- Last 5 years (5)
- Last 10 years (6)
Journals and Conferences
5528Background: Adding BEV to chemotherapy (cisplatin + P or topotecan + P) for advanced (a)CC significantly improved overall and progression-free survival (PFS) in the overall population in GOG240...
Objective: To analyze differences in survival between black and non-black women diagnosed with cervical cancer and treated at the National Cancer Institute in Brazil. Methods: This retrospective… (More)
10072Background: Anthracyclines continue to rank among the most effective agents in Breast Cancer (BC) treatment, but its use is limited by a dose-dependent cardiotoxicity. Clinical studies have… (More)
A Associacao de Combate ao Câncer do Centro-Oeste de Minas, uma organizacao nao governamental que subsidia financeiramente uma estrutura com abrangencia na integralidade dos cuidados do paciente com… (More)
e17509Background: Cervical cancer (CC) is the fourth most common malignancy in women worldwide and third in Brazil. It is a health problem in in low and middle-income countries (LMIC), where most s...
e17510Background: Cervical cancer (CC) is the fourth most common malignancy in women worldwide and around 85% of the cases are currently diagnosed in underdeveloped countries. Effective screening w...